Yaping Wang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Evaluation of pegylated interferon-α therapy efficacy in patients with inactive hepatitis B surface antigen carrier state.
Journal: Scandinavian journal of gastroenterology
Published: April 01, 2026
Triple IFN pathway deficiency sensitizes mice to human respiratory virus infection independent of human viral receptor expression.
Journal: Nature communications
Published: February 13, 2026
The CCL2-CCR2-Ly6c + macrophage axis in PegIFNα-2b therapy for chronic hepatitis B.
Journal: Immunobiology
Published: February 05, 2026
Chinese Guidelines for Clinical Diagnosis, Treatment, and Management of Cirrhosis (2025).
Journal: Journal of clinical and translational hepatology
Published: October 05, 2025
Astragaloside IV reduces hepatitis B surface antigen level via monocyte/macrophages in chronic HBV infection mice.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 30, 2025
Impact of Non-Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha.
Journal: Journal of viral hepatitis
Published: May 15, 2025
Type 2 diabetes mellitus wake-up call: fatal streptococcal toxic shock syndrome triggered by the M1(UK) Streptococcus pyogenes - a case report with genomic insights.
Journal: BMC infectious diseases
Published: April 16, 2025
A hepatitis B virus-free cccDNA-producing stable cell for antiviral screening.
Journal: Antiviral research
Published: November 04, 2024
Interferon stimulated immune profile changes in a humanized mouse model of HBV infection.
Journal: Nature communications
Published: February 25, 2023
Bioactive polysaccharides from lotus as potent food supplements: a review of their preparation, structures, biological features and application prospects.
Journal: Frontiers in nutrition
Published: February 21, 2023
Publisher Correction: Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections.
Journal: Nature communications
Published: September 06, 2022
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants.
Journal: Nature communications
Published: June 17, 2022
Last Updated: 09/26/2026